AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification

• Adam G. Sowalsky,
• Adam Sharp,
• Shana Y. Trostel,
• Johann S. de Bono,
• Stephen R. Plymate

Affiliations

Adam G. Sowalsky

Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, Bethesda, MD, United States; Corresponding author: Adam Sowalsky, 37 Convent Drive, Building 37, Room 1062B, Bethesda, MD 20892.

Adam Sharp

The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom

Shana Y. Trostel

Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, NIH, Bethesda, MD, United States

Johann S. de Bono

The Institute of Cancer Research, London, United Kingdom; The Royal Marsden, London, United Kingdom

Stephen R. Plymate

Department of Medicine, University of Washington, Seattle, WA, United States; Puget Sound VA Health Care System, Geriatric Research Education and Clinical Center, Seattle, WA, United States